| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |